BMI1 and neoplasm: Comparable to the effect of Cisplatin, treatment with Metformin (diabetes drug that has exhibited anticancer properties in various other cancers) lead to a reduction in bulk tumor cells but an increase in CSCs and Bmi-1 expression in HNSCC.